Client

Novalik Pharma is a modern pharmaceutical company specializing in the development, production, and distribution of pharmaceutical products, dietary supplements, and health-support solutions. The company focuses on innovative pharmaceutical solutions and operates according to high product quality standards.

Challenge
The key challenge was promoting a diverse portfolio of pharmaceutical products with different target audiences, consumer journeys, and communication objectives within a unified marketing strategy. Additional complexity came from the need to simultaneously increase brand awareness, drive sales across offline pharmacies and digital channels, and promote products in sensitive categories with advertising restrictions. The objective was to ensure effective communication with relevant audience segments and convert interest into measurable sales.

Strategy

A performance-driven digital strategy was developed to promote Novalik Pharma’s product portfolio, taking into account the specifics of each product and its customer journey. The multichannel approach leveraged Google Ads, Performance Max, Search, Display, Facebook Ads, and radio campaigns with segmented advertising messages tailored to each product. Campaign performance was strengthened through new creative concepts, continuous optimization, and a strong focus on driving conversions and sales.

Geo & Audience
Ukraine. Women of reproductive age, pregnant women, women in menopause, men aged 35+, as well as consumers seeking treatment for musculoskeletal conditions.

Impact

The comprehensive performance strategy drove sales growth across Novalik Pharma’s product portfolio in both offline pharmacies and digital channels. Through a segmented approach, multichannel promotion, and continuous campaign optimization, the strategy strengthened the brand’s market position, improved customer acquisition efficiency, and delivered stable conversion growth across multiple product categories.

Result
  • Offline pharmacy sales of Folionation increased by 23% 
  • Sales of Declimans increased by 11% in offline pharmacies and by 29% via novalik.com 
  • Conversions for Declimans increased by 42% 
  • Sales of Tribustim via novalik.com increased by 14% despite category advertising restrictions 
  • Conversions for Tribustim increased by 23.5% 
  • Sales of Neokaripazim via the website increased by 7%, while conversions increased by 14%